Spironolactone Tablet, Film Coated
Product Images NDC 51079-979

9 FDA label images from Mylan Institutional Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 51079-979). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spironolactone 50 mg Tablets Unit Carton Label (Image 01)

Spironolactone 50 mg Tablets Unit Carton Label (Image 01)
Chemical structure diagram of spironolactone, showing its steroid backbone with attached functional groups including ketone, ester, and thioacetate moieties.*
FDA Label Image

Spironolactone 25 mg Tablets Unit Carton Label (Image 02)

Spironolactone 25 mg Tablets Unit Carton Label (Image 02)
A Kaplan-Meier survival curve comparing Spironolactone and placebo over 48 months. The y-axis represents probability, and the x-axis shows time in months. The curve shows a higher survival probability for Spironolactone (n=822) than placebo (n=841), with a log-rank p-value less than 0.001, indicating statistical significance.*
FDA Label Image

Unit Carton (Image 03)

Unit Carton (Image 03)
A forest plot figure showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups related to spironolactone treatment versus placebo. Subgroups include age ranges, sex, race, LVEF %, heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, and use of digoxin, ACE inhibitors (ACEI), and beta blockers. The plot depicts individual subgroup risk estimates and confidence intervals along a horizontal axis ranging approximately from 0.2 to 1.4, with annotations indicating "Spironolactone better" on the left and "Placebo better" on the right.*
FDA Label Image

Unit Carton (Image 04)

Unit Carton (Image 04)
Spironolactone 25 mg film-coated tablets label showing the product name, strength, dosage form, and NDC 51079-103-20. The package contains 100 tablets (10 x 10) by Mylan Pharmaceuticals Inc., Morgantown, WV. The label includes basic storage instructions and a barcode, with Mylan branding at the bottom.*
FDA Label Image

Spironolactone 100 mg Tablets Unit Carton Label (Image 05)

Spironolactone 100 mg Tablets Unit Carton Label (Image 05)
Packaging label for Mylan Institutional Inc. unit-dose blister pack. The front side is blue with safety and usage instructions indicating the package is not child resistant, intended for institutional use, and provides light resistance. The back has a white label with a QR code and lot number, as well as expiration date details visible through a window. No specific dosage strength or medication name is shown on the visible panel.*
FDA Label Image

Unit Carton (Image 06)

Unit Carton (Image 06)
Spironolactone 50 mg tablets, USP, film coated oral tablets manufactured by Mylan Pharmaceuticals Inc. The label shows the tablet imprint "M 243" and contains 100 tablets in a 10 x 10 count. It includes storage instructions and a barcode, with Mylan branding at the bottom.*
FDA Label Image

Image 07

Image 07
Unit-dose packaging for Spironolactone tablets distributed by Mylan Institutional Inc. The front side is blue with white text including usage instructions and a Mylan logo. The back side has a white label with a QR code and spaces designated for lot number and expiration date information.*
FDA Label Image

Image 08

Image 08
Label for Spironolactone Tablets USP 100 mg by Mylan Institutional Inc., showing a film-coated tablet imprinted with "M 437." The label includes packaging details of 80 tablets, storage instructions, and manufacturer information for Mylan Pharmaceuticals Inc., Morganton, WV.*
FDA Label Image

Image 09

Image 09
Unit-dose packaging label for Spironolactone tablets, film coated, distributed by Mylan Institutional Inc. The label emphasizes institutional use with warnings about child resistance, light resistance, and proper drug handling. It includes a window for lot number and expiration date information and displays the Mylan logo and distributor address in Rockford, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.